Current fundraisers

OncoSynergy GBM Trial Fund

OncoSynergy has joined forces with the Musella Foundation to raise funds for the company’s FDA approved Phase 1 clinical trial in recurrent glioblastoma.

OncoSynergy is ready to bring its innovative solution to patients. Our goal is to raise at least $60,000 to fund treatment of at least 1 patient in our FDA approved trial. With your support, we hope to exceed this goal and be able to treat more glioblastoma patients. Each patient we treat helps us and the oncology community better understand how our therapeutic, OS2966, works against cancer. This is powerful information that will allow us to address the shortcomings of today’s approach to cancer and translate this cancer treatment to the entire oncology population.